Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The molecular basis for responsiveness to anti-viral therapy in hepatitis C.

Forum (Genoa, Italy) - 1 Jan 2000

Polyak S J, Gerotto M

Abstract excerpt

Hepatitis C virus (HCV) infection is an important clinical problem, with a world-wide prevalence of approximately 1-2%. HCV infection is associated with an increased risk for the development of severe liver disease. HCV is inherently resistant to anti-viral therapy with interferon (IFN). The virus circulates in infected individuals as a mixture of related, yet genetically distinct variants, or quasispecies. Many...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Combinations
Share to Drug Resistance, Microbial
Share to Interferons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Diseases

Share to Molecular Biology

Share to Ribavirin

Share to Viral Envelope Proteins

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 10717257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The molecular basis for responsiveness to anti-viral therapy in hepatitis C.PMID 10717257Read ↗

Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.Semantic proximity Read ↗

Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizonSemantic proximity Read ↗

Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.Semantic proximity Read ↗

Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.Semantic proximity Read ↗

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Semantic proximity Read ↗

Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.Semantic proximity Read ↗

Molecular tools for the treatment of hepatitis C.Semantic proximity Read ↗

Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.Semantic proximity Read ↗

The molecular biology of hepatitis C virus. Genotypes and quasispecies.Semantic proximity Read ↗

Resistance to direct antiviral agents in patients with hepatitis C virus infection.Semantic proximity Read ↗

Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.Semantic proximity Read ↗

Hepatitis C virus and interferon resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.